Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF.

Lee TC, Qian M, Liu Y, Graham S, Mann DL, Nakanishi K, Teerlink JR, Lip GYH, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Matsumoto K, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Di Tullio MR; WARCEF Investigators.

JACC Heart Fail. 2019 Dec;7(12):1042-1053. doi: 10.1016/j.jchf.2019.09.003.

PMID:
31779926
2.

Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.

MacInnis RJ, Liao Y, Knight JA, Milne RL, Whittemore AS, Chung WK, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, McLachlan SA, Weideman PC, Nesci S, Friedlander ML, Glendon G; kConFab Investigators, Andrulis IL, John EM, Daly MB, Buys SS, Phillips KA, Hopper JL, Terry MB.

J Natl Cancer Inst. 2019 Oct 4. pii: djz194. doi: 10.1093/jnci/djz194. [Epub ahead of print]

PMID:
31584660
3.

Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.

Lee TC, Qian M, Mu L, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Lip GYH, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S; WARCEF Investigators.

ESC Heart Fail. 2019 Apr;6(2):297-307. doi: 10.1002/ehf2.12407. Epub 2019 Feb 27.

4.

10-year performance of four models of breast cancer risk: a validation study.

Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S, Andrulis IL, John EM, Phillips KA, Daly MB, Buys SS, Hopper JL, MacInnis RJ.

Lancet Oncol. 2019 Apr;20(4):504-517. doi: 10.1016/S1470-2045(18)30902-1. Epub 2019 Feb 21.

PMID:
30799262
5.

Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.

Terry MB, Daly MB, Phillips KA, Ma X, Zeinomar N, Leoce N, Dite GS, MacInnis RJ, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, Weideman PC, Glendon G, Buchsbaum R, Andrulis IL, John EM, Buys SS, Hopper JL.

J Natl Cancer Inst. 2019 Mar 1;111(3):331-334. doi: 10.1093/jnci/djy182.

6.

Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use.

Chen B, Choi H, Hirsch LJ, Legge A, Buchsbaum R, Detyniecki K.

Seizure. 2018 Nov;62:38-42. doi: 10.1016/j.seizure.2018.09.014. Epub 2018 Sep 22.

7.

Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).

Lee TC, Qian M, Lip GYH, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S; WARCEF Investigators.

Am J Cardiol. 2018 Sep 1;122(5):821-827. doi: 10.1016/j.amjcard.2018.05.024. Epub 2018 Jun 4.

8.

Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.

Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

ESC Heart Fail. 2018 Oct;5(5):800-808. doi: 10.1002/ehf2.12331. Epub 2018 Jul 17.

9.

Comparative efficacy of unique antiepileptic drug regimens in focal epilepsy: An exploratory study.

Legge AW, Detyniecki K, Javed A, Hirsch LJ, Kato K, Buchsbaum R, Chen B, Choi H.

Epilepsy Res. 2018 May;142:73-80. doi: 10.1016/j.eplepsyres.2018.03.011. Epub 2018 Mar 10.

PMID:
29571152
10.

Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trial.

Stacpoole PW, Shuster J, Thompson JLPS, Prather RA, Lawson LA, Zou B, Buchsbaum R, Nixon SJ.

Mitochondrion. 2018 Sep;42:59-63. doi: 10.1016/j.mito.2017.11.003. Epub 2017 Nov 10.

11.

Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.

Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R, Detyniecki K.

Epilepsy Behav. 2017 Nov;76:24-31. doi: 10.1016/j.yebeh.2017.08.039. Epub 2017 Sep 18. Review.

PMID:
28931473
12.

Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.

Antropow AH, Xu K, Buchsbaum RJ, Movassaghi M.

J Org Chem. 2017 Aug 4;82(15):7720-7731. doi: 10.1021/acs.joc.7b01162. Epub 2017 Jul 25.

13.

Prevalence and risk factors of seizure clusters in adult patients with epilepsy.

Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Wong RA, Jiang A, Kato K, Buchsbaum R, Detyniecki K.

Epilepsy Res. 2017 Jul;133:98-102. doi: 10.1016/j.eplepsyres.2017.04.016. Epub 2017 Apr 27.

PMID:
28475999
14.

Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.

Nakanishi K, Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

Cerebrovasc Dis. 2017;44(1-2):43-50. doi: 10.1159/000474958. Epub 2017 Apr 19.

15.

Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy.

Chen B, Detyniecki K, Choi H, Hirsch L, Katz A, Legge A, Wong R, Jiang A, Buchsbaum R, Farooque P.

Eur J Paediatr Neurol. 2017 May;21(3):441-449. doi: 10.1016/j.ejpn.2017.02.003. Epub 2017 Feb 14.

PMID:
28238621
16.

Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.

Shah GL, Winn A, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK.

Bone Marrow Res. 2016;2016:3645623. Epub 2016 Oct 18.

17.

Medicare's site-neutral payment impact on hospital outpatient services.

Price J, Buchsbaum R, Price K.

Healthc Financ Manage. 2016 Nov;70(11):80-6. No abstract available.

PMID:
29897220
18.

In response: Drug-resistant epilepsy in adults: outcome trajectories after failure of two medications.

Choi H, Hayat MJ, Zhang R, Hirsch LJ, Bazil C, Mendiratta A, Kato K, Javed A, Legge AW, Buchsbaum R, Resor S, Heiman G.

Epilepsia. 2016 Sep;57(9):1526-7. doi: 10.1111/epi.13487. No abstract available.

19.

CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.

Ye S, Qian M, Zhao B, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Lip GY, Thompson JL, Homma S; WARCEF Investigators.

Eur J Heart Fail. 2016 Oct;18(10):1261-1266. doi: 10.1002/ejhf.613. Epub 2016 Jul 21.

20.

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.

Di Tullio MR, Qian M, Thompson JL, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GY, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

Stroke. 2016 Aug;47(8):2031-7. doi: 10.1161/STROKEAHA.116.013679. Epub 2016 Jun 28.

21.

Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications.

Choi H, Hayat MJ, Zhang R, Hirsch LJ, Bazil CW, Mendiratta A, Kato K, Javed A, Legge AW, Buchsbaum R, Resor S, Heiman GA.

Epilepsia. 2016 Jul;57(7):1152-60. doi: 10.1111/epi.13406. Epub 2016 Jun 6.

22.

Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.

Huang X, MacIsaac R, Thompson JL, Levin B, Buchsbaum R, Haley EC Jr, Levi C, Campbell B, Bladin C, Parsons M, Muir KW.

Int J Stroke. 2016 Jul;11(5):534-43. doi: 10.1177/1747493016641112. Epub 2016 Apr 5.

PMID:
27048693
23.

Where is the leak in the pipeline? Investigating gender differences in academic promotion at an academic medical centre.

Paulus JK, Switkowski KM, Allison GM, Connors M, Buchsbaum RJ, Freund KM, Blazey-Martin D.

Perspect Med Educ. 2016 Apr;5(2):125-8. doi: 10.1007/s40037-016-0263-7.

24.

Development and Feasibility Testing of a Critical Care EEG Monitoring Database for Standardized Clinical Reporting and Multicenter Collaborative Research.

Lee JW, LaRoche S, Choi H, Rodriguez Ruiz AA, Fertig E, Politsky JM, Herman ST, Loddenkemper T, Sansevere AJ, Korb PJ, Abend NS, Goldstein JL, Sinha SR, Dombrowski KE, Ritzl EK, Westover MB, Gavvala JR, Gerard EE, Schmitt SE, Szaflarski JP, Ding K, Haas KF, Buchsbaum R, Hirsch LJ, Wusthoff CJ, Hopp JL, Hahn CD; Critical Care EEG Monitoring Research Consortium (CCEMRC).

J Clin Neurophysiol. 2016 Apr;33(2):133-40. doi: 10.1097/WNP.0000000000000230.

25.

Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go.

Buchsbaum RJ, Oh SY.

Cancers (Basel). 2016 Jan 27;8(2). pii: E19. doi: 10.3390/cancers8020019. Review.

26.

The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.

Xu K, Tian X, Oh SY, Movassaghi M, Naber SP, Kuperwasser C, Buchsbaum RJ.

Breast Cancer Res. 2016 Jan 28;18(1):14. doi: 10.1186/s13058-016-0674-8.

27.

The first prognostic model for stroke and death in patients with systolic heart failure.

Freudenberger RS, Cheng B, Mann DL, Thompson JL, Sacco RL, Buchsbaum R, Sanford A, Pullicino PM, Levin B, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Di Tullio MR, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

J Cardiol. 2016 Aug;68(2):100-3. doi: 10.1016/j.jjcc.2015.09.014. Epub 2015 Nov 6.

28.

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.

Ye S, Cheng B, Lip GY, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Qian M, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators.

Am J Cardiol. 2015 Sep 15;116(6):904-12. doi: 10.1016/j.amjcard.2015.06.016. Epub 2015 Jun 24.

29.

Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-up.

Javed A, Cohen B, Detyniecki K, Hirsch LJ, Legge A, Chen B, Bazil C, Kato K, Buchsbaum R, Choi H.

Seizure. 2015 Jul;29:34-40. doi: 10.1016/j.seizure.2015.03.013. Epub 2015 Mar 24.

30.

Ultra-sensitive protein detection via Single Molecule Arrays towards early stage cancer monitoring.

Schubert SM, Arendt LM, Zhou W, Baig S, Walter SR, Buchsbaum RJ, Kuperwasser C, Walt DR.

Sci Rep. 2015 Jun 8;5:11034. doi: 10.1038/srep11034.

31.

Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database.

Shah GL, Winn AN, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1823-9. doi: 10.1016/j.bbmt.2015.05.013. Epub 2015 May 30.

32.

Cross-sensitivity of patient-perceived adverse cognitive effects with antiepileptic drug use.

Chen B, Detyniecki K, Hirsch LJ, Moeller J, Javed A, Kato K, Legge A, Buchsbaum R, Choi H.

Epilepsy Behav. 2015 May;46:151-7. doi: 10.1016/j.yebeh.2015.03.020. Epub 2015 Apr 30.

PMID:
25935515
33.

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators.

Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7.

34.

Cosmetic side effects of antiepileptic drugs in adults with epilepsy.

Chen B, Choi H, Hirsch LJ, Moeller J, Javed A, Kato K, Legge A, Buchsbaum R, Detyniecki K.

Epilepsy Behav. 2015 Jan;42:129-37. doi: 10.1016/j.yebeh.2014.10.021. Epub 2014 Dec 13.

PMID:
25513768
35.

Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobules.

Arendt LM, Keller PJ, Skibinski A, Goncalves K, Naber SP, Buchsbaum RJ, Gilmore H, Come SE, Kuperwasser C.

Breast Cancer Res. 2014 Oct 15;16(5):453. doi: 10.1186/s13058-014-0453-3.

36.

The Drowning Index: implementation in drowning, mechanical asphyxia, and acute myocardial infarct cases.

Wardak KS, Buchsbaum RM, Walyzada F.

J Forensic Sci. 2014 Mar;59(2):399-403. doi: 10.1111/1556-4029.12356. Epub 2014 Feb 15.

PMID:
24528098
37.

Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.

Reich-Slotky R, Andrews J, Cheng B, Buchsbaum R, Levy D, Kaufmann P, Thompson JL.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr;14(3):212-6. doi: 10.3109/21678421.2013.770028. Epub 2013 Mar 1.

PMID:
23452274
38.

Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Longstreth WT Jr, Kronmal RA, Thompson JL, Christenson RH, Levine SR, Gross R, Brey RL, Buchsbaum R, Elkind MS, Tirschwell DL, Seliger SL, Mohr JP, deFilippi CR.

Stroke. 2013 Mar;44(3):714-9. doi: 10.1161/STROKEAHA.112.675942. Epub 2013 Jan 22.

39.

Isolation of mammary epithelial cells from three-dimensional mixed-cell spheroid co-culture.

Xu K, Buchsbaum RJ.

J Vis Exp. 2012 Apr 30;(62). pii: 3760. doi: 10.3791/3760.

40.

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators.

N Engl J Med. 2012 May 17;366(20):1859-69. doi: 10.1056/NEJMoa1202299. Epub 2012 May 2.

41.

Tiam1-regulated osteopontin in senescent fibroblasts contributes to the migration and invasion of associated epithelial cells.

Liu J, Xu K, Chase M, Ji Y, Logan JK, Buchsbaum RJ.

J Cell Sci. 2012 Jan 15;125(Pt 2):376-86. doi: 10.1242/jcs.089466. Epub 2012 Feb 2.

42.

The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy.

Arif H, Svoronos A, Resor SR Jr, Buchsbaum R, Hirsch LJ.

Epilepsia. 2011 Oct;52(10):1905-13. doi: 10.1111/j.1528-1167.2011.03217.x. Epub 2011 Aug 12.

43.

The role of fibroblast Tiam1 in tumor cell invasion and metastasis.

Xu K, Rajagopal S, Klebba I, Dong S, Ji Y, Liu J, Kuperwasser C, Garlick JA, Naber SP, Buchsbaum RJ.

Oncogene. 2010 Dec 16;29(50):6533-42. doi: 10.1038/onc.2010.385. Epub 2010 Aug 30.

44.

Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.

Arif H, Buchsbaum R, Pierro J, Whalen M, Sims J, Resor SR Jr, Bazil CW, Hirsch LJ.

Arch Neurol. 2010 Apr;67(4):408-15. doi: 10.1001/archneurol.2010.49.

PMID:
20385905
45.

Scaffold proteins IRSp53 and spinophilin regulate localized Rac activation by T-lymphocyte invasion and metastasis protein 1 (TIAM1).

Rajagopal S, Ji Y, Xu K, Li Y, Wicks K, Liu J, Wong KW, Herman IM, Isberg RR, Buchsbaum RJ.

J Biol Chem. 2010 Jun 4;285(23):18060-71. doi: 10.1074/jbc.M109.051490. Epub 2010 Apr 1.

46.

Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial.

Haley EC Jr, Thompson JL, Grotta JC, Lyden PD, Hemmen TG, Brown DL, Fanale C, Libman R, Kwiatkowski TG, Llinas RH, Levine SR, Johnston KC, Buchsbaum R, Levy G, Levin B; Tenecteplase in Stroke Investigators.

Stroke. 2010 Apr;41(4):707-11. doi: 10.1161/STROKEAHA.109.572040. Epub 2010 Feb 25.

47.

Web-based data management for a phase II clinical trial in ALS.

Buchsbaum R, Kaufmann P, Barsdorf AI, Arbing R, Montes J, Thompson JL; QALS Study Group.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):374-7. doi: 10.3109/17482960802378998.

48.

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group.

Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743.

49.

Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs.

Arif H, Buchsbaum R, Weintraub D, Pierro J, Resor SR Jr, Hirsch LJ.

Epilepsy Behav. 2009 Jan;14(1):202-9. doi: 10.1016/j.yebeh.2008.10.017. Epub 2008 Dec 17.

PMID:
19010446
50.

Cross-sensitivity of skin rashes with antiepileptic drug use.

Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR Jr, Bazil CW.

Neurology. 2008 Nov 4;71(19):1527-34. doi: 10.1212/01.wnl.0000334295.50403.4c.

PMID:
18981374

Supplemental Content

Loading ...
Support Center